Commentary: Past, Present, and Future of Equine Stem Cells
Equine Disease Quarterly
July 6, 2012
One veterinarian shares his thoughts on the past, present, and future of stem cells in equine medicine.
One veterinarian shares his thoughts on the past, present, and future of stem cells in equine medicine.
A complete feed at recommended levels can provide calories for horses who don’t get enough from forage alone.
Study finds that dexamethasone (DXM) behaves similarly regardless of how it enters the horse’s body.
Appropriate forage, forage alternatives, and/or concentrates can keep aged horses at a healthy body condition.
Certain feeding strategies can help your horse weather equine Cushing’s disease.
Test for the common endocrine disorders Cushing’s disease and equine metabolic syndrome and treat accordingly.
Firocoxib improved lameness scores, comfort, and mobility in most horses with osteoarthritis, a study showed.
Joint disease is a common lameness cause and a primary reason why many horses’ athletic careers end.
An understanding of how the biology of aging affects the older horse has become increasingly important.
The change comes several months after the FDA approved a pergolide mesylate tablet for use in horses.
A new FDA-approved Pergolide product offers options in the management of clinical signs associated with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease.
A reader is concerned about her 24-year-old easy keeper’s weight loss and sudden difficulty keeping weight on.
The objective of the survey is to determine the prevalence of Cushing’s disease worldwide.
Patella infections in foals, while uncommon, can result in prolonged and severe stifle joint infection.
Season variations in ACTH levels are found in some geographic areas, while no changes take place in others.
The study will test a novel neutriceutical for the treatment of lameness in horses due to osteoarthritis.
Stay on top of the most recent Horse Health news with
